A novel electrospraying technology platform for controlled and targeted growth factor delivery. This project will develop a new growth factor delivery strategy to stimulate bone regeneration. The project will utilise the technique of electrospraying to create small dissolving polymer microspheres containing bone-relevant growth factors, which are released gradually as the polymer degrades after implantation into a bone defect site to promote healing.
Multifunctional surfaces for implantable biomedical devices. This project aims to improve the quality of life of patients receiving biomedical implants. The project will develop new plasma processing methods to create surfaces for implants that will give control over the response of human tissues. Tissue integration with the device will be achieved where required and infection suppressed.
Clean technologies for the synthesis and purification of a biohybrid and biodegradable polymer. The project aims to transform an Australian industry in the forefront of the global market for manufacturing biodegradable polymers and boost export earnings derived from CO2 based biohybrid polymers. The project will develop cost-effective and clean methods for processing CO2 based polymers and demonstrate its potential for packaging and biomedical applications.
Nanoporous siloxane membranes for ultrasound mediated ophthalmic drug delivery. This project will develop tailored polymers for use in a novel non-invasive ocular drug delivery device which treats vision threatening conditions such as age-related macular degeneration (AMD). The outcomes of this project will enable an entirely new ocular drug delivery technology, thereby delivering significant benefit to ophthalmic healthcare.